Veradermics, Inc

MANE chart

Veradermics, Inc news

• Top Veradermics (MANE) Competitors 2026

  MarketBeat · Oct 27, 8:53 AM EDT

• A New Hair Loss Pill Moves Closer To FDA Approval After A Positive Clinical Trial Involving Over 500 Balding Men

  IFLScience · Oct 26, 6:28 PM EDT

• Veradermics (MANE) Short Interest & Short Float | Updated Oct 2026

  MarketBeat · Oct 26, 6:04 PM EDT

• New oral treatment shows promise in combating pattern baldness

  SSBCrack · Oct 25, 5:24 PM EDT

• Men battling baldness may soon have a new pill to turn to

  New York Post · Oct 25, 4:41 PM EDT

• The week in pharma: action, reaction and insight – week to October 23, 2026

  The Pharmaletter · Oct 25, 12:44 PM EDT

• Why This Hair Restoration Biotech's Shares Are Soaring

  fool.com · Oct 25, 9:20 AM EDT

• Veradermics (MANE) Options Chain & Prices 2026

  MarketBeat · Oct 23, 3:00 AM EDT

• Veradermics Price Target Raised to $204.00/Share From $170.00 by B. Riley Securities

  Moomoo · Oct 23, 2:17 AM EDT

• Veradermics (MANE) Ticks Up 0.58% to $137.46, Holding Above Key Support - Ascending Triangle

  https://www.siam.in/ · Oct 22, 3:30 PM EDT

• Health: Veradermics' oral hair-loss drug shown to boost hair growth in late-stage study

  Gulf Daily News (Bahrain) · Oct 22, 8:38 AM EDT

• B. Riley Raises Price Target on Veradermics to $204 From $170, Keeps Buy Rating

  Yahoo Finance · Oct 22, 8:07 AM EDT

Veradermics, Inc key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-10-19
• 10-Q10-Q2026-08-11
• 8-K8-K2026-08-11
• S-1S-12026-08-07
• 8-K8-K2026-07-15
• 10-Q10-Q2026-05-12
• 8-K8-K2026-05-12
• 8-K8-K2026-05-01
• S-1S-12026-04-27
• 8-K8-K2026-04-27
• 8-K8-K2026-04-27
• 10-K10-K2026-03-30

About Veradermics, Inc

Ticker

MANE (NYSE)

Industry

Pharmaceutical Preparations

Headquarters

New Haven, CT

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1827635

Frequently asked questions